Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Fortrea Holdings Inc. - Common Stock (NQ:FTRE)

15.83 +0.51 (+3.33%)
Streaming Delayed Price Updated: 10:07 AM EDT, Jun 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Research
Quarterly Reports Insider Filings Other Filings

All News about Fortrea Holdings Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Q4 Earnings Highs And Lows: Fortrea (NASDAQ:FTRE) Vs The Rest Of The Drug Development Inputs & Services Stocks
Via StockStory
News headline image
Fortrea (FTRE) Q4 2025 Earnings Call Transcript ↗
Fortrea (FTRE) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
Fortrea Holdings Inc (NASDAQ:FTRE) Reports Mixed Q4 2025 Results and Cautious 2026 Outlook ↗
Via Chartmill
News headline image
Fortrea (NASDAQ:FTRE) Reports Sales Below Analyst Estimates In Q4 CY2025 Earnings
Clinical research company Fortrea Holdings (NASDAQ:FTRE) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 5.2% year on year to $660.5 million. The company’s full-year... 
Via StockStory
News headline image
Fortrea Reports Fourth Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Earnings To Watch: Fortrea (FTRE) Reports Q4 Results Tomorrow
Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be announcing earnings results tomorrow morning. Here’s what to expect. 
Via StockStory
Topics Artificial Intelligence
News headline image
iRhythm, agilon health, GoodRx, Fortrea, and Myriad Genetics Stocks Trade Down, What You Need To Know
A number of stocks fell in the morning session after the Trump administration's announcement of new global tariffs reignited trade policy uncertainty. The move came swiftly after the Supreme Court... 
Via StockStory
Topics Government World Trade
News headline image
1 Russell 2000 Stock to Target This Week and 2 That Underwhelm
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
News headline image
3 Reasons to Sell FTRE and 1 Stock to Buy Instead
Over the past six months, Fortrea has been a great trade, beating the S&P 500 by 28.1%. Its stock price has climbed to $10.64, representing a healthy 34.8% increase. This was partly due to its solid... 
Via StockStory
Topics Stocks
News headline image
Fortrea Expands Executive Team, Appointing Oren Cohen as Chief Medical Officer and Scott Dove as President of Clinical Pharmacology Services
Adds to executive focus on early clinical development and deepens medical and scientific partnership with clients 
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea Announces Date for Fourth Quarter and Full Year 2025 Financial Results and Conference Call
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
2 Unprofitable Stocks with Promising Prospects and 1 We Turn Down
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital... 
Via StockStory
News headline image
Why Fortrea (FTRE) Stock Is Trading Up Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 4.8% in the afternoon session after Evercore ISI upgraded the stock to Outperform from In Line and significantly raised its... 
Via StockStory
Topics Artificial Intelligence Initial Public Offering Supply Chain
News headline image
Fortrea Announces Updated Presentation Time at Upcoming J.P. Morgan Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Fortrea to Present at Upcoming J.P. Morgan Healthcare Conference
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
3 Small-Cap Stocks Walking a Fine Line
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a... 
Via StockStory
News headline image
3 Unpopular Stocks We Steer Clear Of
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps... 
Via StockStory
News headline image
3 Inflated Stocks with Open Questions
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
News headline image
3 Stocks Under $50 Walking a Fine Line
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
News headline image
Why Fortrea (FTRE) Stock Is Up Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 8% in the afternoon session after an analyst at Mizuho raised the firm's price target on the stock while maintaining a Neutral... 
Via StockStory
Topics Initial Public Offering
News headline image
Why Fortrea (FTRE) Stock Is Trading Up Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 5.7% in the morning session after an analyst at Mizuho raised the company's price target. Analyst Ann Hynes reaffirmed a... 
Via StockStory
Topics Initial Public Offering
News headline image
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Molina Healthcare, Inc. (NYSE: MOH); and Synopsys, Inc. (NASDAQ: SNPS): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Why Fortrea (FTRE) Stock Is Up Today
Shares of clinical research company Fortrea Holdings (NASDAQ:FTRE) jumped 6.2% in the afternoon session after Citigroup upgraded the stock's rating to Buy from Neutral and significantly raised its... 
Via StockStory
Topics Artificial Intelligence Initial Public Offering
News headline image
Important Notice to Long-Term Shareholders of Alexandria Real Estate Equities, Inc. (NYSE: ARE); CarMax, Inc. (NYSE: KMX); Fortrea Holdings, Inc. (NASDAQ: FTRE); StubHub Holdings, Inc. (NYSE: STUB): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Attention Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Synopsys, Inc. (NASDAQ: SNPS); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office Investigates Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
News headline image
SCTbio and Fortrea Forge Strategic Collaboration to Accelerate Cell and Gene Therapy Development and Delivery
From Fortrea Holdings Inc
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Unicycive Therapeutics, Inc. (NASDAQ: UNCY); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims
From Grabar Law Office
Via GlobeNewswire
News headline image
Important Notice to Long-Term Shareholders of Cytokinetics, Inc. (NASDAQ: CYTK); Fortrea Holdings, Inc. (NASDAQ: FTRE); Ibotta, Inc. (NYSE: IBTA); and WEBTOON Entertainment Inc. (NASDAQ: WBTN): Grabar Law Office is Investigating Claims on Your Behalf
From Grabar Law Office
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.